RxDoctor Payments Data

Joseph Chase, MD

Family Medicine · Stow, OHNPI 1508858358

Payments from drug & device makers

$6,867in general payments, 2019–2025

Across 460 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Pfizer$875
  • AbbVie$768
  • Amgen$402
  • Astellas Pharma US Inc$326
  • Lilly USA, LLC$316
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$6,860100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,867 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$86,043
Medicare patients
237
Services billed
1,294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban270$163,948
JardianceEmpagliflozin66$75,782
OzempicSemaglutide50$53,533
TrulicityDulaglutide36$40,639
FarxigaDapagliflozin Propanediol17$27,668
MyrbetriqMirabegron68$25,905
MounjaroTirzepatide14$22,856
EntrestoSacubitril/Valsartan44$21,038
XareltoRivaroxaban16$14,901
Carbidopa14$13,480
Memantine Hcl109$7,567
BelsomraSuvorexant18$7,423
GemtesaVibegron20$7,074
Atorvastatin Calcium629$6,710
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate29$5,976

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$875$163,948270 claims
Boehringer IngelheimJardiance$80$75,78266 claims
Lilly USA, LLCTrulicity, Mounjaro$316$63,49550 claims
Novo NordiskOzempic$275$53,53350 claims
AstraZenecaFarxiga$88$27,66817 claims
Astellas Pharma US IncMyrbetriq$326$25,90568 claims
NovartisEntresto$216$21,03844 claims
Johnson & JohnsonXarelto$56$14,90116 claims
MerckBelsomra$265$7,42318 claims
Sumitomo Pharma America, Inc.Gemtesa$69$7,07420 claims
AbbVieCombigan, Synthroid$768$4,39970 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Stow

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →